Besivance

DRUG3 trials

Sponsors

Bausch & Lomb Incorporated, Ophthalmology Consultants, Ltd.

Conditions

Bacterial ConjunctivitisCataract SurgeryCorneal Health

Phase 3

Safety of Besivance™ (Besifloxacin Ophthalmic Suspension) 0.6% Compared to Vehicle

CompletedNCT01175590

Bausch & Lomb IncorporatedBacterial Conjunctivitis

Start: 2010-06-30End: 2012-02-29Updated: 2013-05-01

Besifloxacin Ophthalmic Suspension Verses Gatifloxacin Ophthalmic Solution in Neonates With Bacterial Conjunctivitis

TerminatedNCT01330355

Bausch & Lomb IncorporatedBacterial Conjunctivitis

Start: 2011-05-31End: 2013-10-31Updated: 2014-09-03

Phase 4

2-Site Safety Study of Besivance Versus Vigamox Prophylactically in Routine Cataract Surgery

CompletedNCT01455233

Ophthalmology Consultants, Ltd.Cataract Surgery, Corneal Health

Start: 2010-09-30End: 2011-02-28Updated: 2011-10-19